EC Pharmacology And Toxicology

Editorial Volume 13 Issue 2 - 2025

Magnetic Water and Field in Anti-Cancer Treatment

Da-Yong Lu* and Hong-Ying Wu

School of Life Sciences, Shanghai University, PR China
*Corresponding Author: Da-Yong Lu, School of Life Sciences, Shanghai University, PR China.
Received: January 08, 2025; Published: January 28, 2025



Cancer is a deadly disease with high rate of human mortality. Cancer treatment contains surgery, radiotherapy, immunotherapy, biotherapy, thermotherapies herbal medicine, chemotherapy and others. Chemotherapy is the most popular option yet has much to improve for its high toxicity, lack of specificity and drug resistance.

Magnetic water, field and nanoparticles have been found to improve dilemma of chemotherapy discussed above. In order to promote cancer treatment by chemotherapy, the mechanisms, pathways and targets of anticancer drugs associated with magnetic waters or others should be known and promoted.

Magnetic water or fields in cancer treatment is a long-lasting topic with modern twist and turn. New researches on mechanism discovery and therapeutic routine establishment may help fostering new knowledge and tradition in hospitals and medicine. Novel initial activities and investigations should be made for better cancer treatments via magnetic-related technology and biomedical knowledge.

 Keywords: Chemotherapy; Anticancer Drugs; Magnetic Water; Cancer Research; Oncology Biology

  1. Lu DY and Lu TR. “Anticancer drug development, challenge and dilemma”. Nursing and Care Open Access3 (2020): 72-75.
  2. Hay M., et al. “Clinical development success rates for investigational drugs”. Nature Biotechnology 32 (2014): 40-51.
  3. Lu DY., et al. “Cancer metastasis treatments”. Current Drug Therapy1 (2013): 24-29.
  4. Lambert AW., et al. “Emerging biological principles of metastasis”. Cell 4 (2017): 670-691.
  5. Gerstberger S., et al. “Metastasis”. Cell8 (2023): 1564-1579.
  6. Lu DY and Xu B. “Cancer bone metastasis, experimental study”. Acta Scientific Orthopeadics11 (2022): 46.
  7. Tanaka T., et al. “Tumor targeting based on the effect of enhanced permeability and retentions (EPR) and the mechanism of receptor-mediated endocytosis (RME)”. International Journal of Pharmaceutics 1-2 (2004): 39-61.
  8. Rageh MM., et al. “Magnetic fields enhance the anti-tumor efficacy of low dose cisplatin and reduce the nephrotoxicity”. Naunyn-Schmiedeberg’s Archives of Pharmacology8 (2020): 1475-1485.
  9. Lu DY., et al. “Effect of magnetized water on the mice given high doses of antineoplastic drugs”. Journal of Shanghai University (England)1 (1999): 81-83.
  10. Lu DY and Wu HY. “Chemotherapy and magnetic water in anticancer treatment”. EC Pharmacology and Toxicology11 (2024): 1-2.
  11. Xiao P., et al. “Experimental observations of magnetic liquid impact on neoplasm cells”. Chin J Phys Med.3 (1985): 159-163.
  12. Spoiala A., et al. “Smarter magnetic drug delivery systems for the treatment of cancer”. Nanomaterials5 (2023): 876.
  13. Lu DY and Lu TR. “Antimetastatic drugs, pharmacologic challenge and opportunity”. Current Drug Therapy2 (2025): 169-179.
  14. Wang DF., et al. “Accelerating the understanding of cancer biology through the lens of genomics”. Cell8 (2023): 1755-1771.
  15. Van Denderen BJW and Thompson EW. “The to and fro of tumour spread”. Nature 7433 (2013): 487-488.
  16. Lu DY., et al. “Cancer metastasis, a clinical dilemma for therapeutics”. Current Drug Therapy2 (2016): 163-169.
  17. Lu DY., et al. “Natural drug cancer treatment strategies from herbal medicine to chemical or biological drug”. Studies in Natural Products Chemistry 66 (2020): 91-115.
  18. Bouhlel M., et al. “Improvement of salt leaching efficacy and water content of soil through irrigation with electro-magnetized saline water”. Water20 (2024): 3010.
  19. Putti FF., et al. “Effect of magnetic water treatment on the growth, nutritional status, and yield of Lettuce plants with irrigation rate”. Horticulturae4 (2023): 504.

Da-Yong Lu and Hong-Ying Wu. “Magnetic Water and Field in Anti-Cancer Treatment”. ”. EC Pharmacology and Toxicology  13.2 (2025): 01-04.